Vote your shares today:
call (855) 643-7453 to speak
to a proxy voting specialist.
A Special Meeting of Stockholders has been
November 2, 2020. Rexahn Stockholders are
being asked to
support all Proposals to help effect a
transaction between Rexahn and Ocuphire
The Rexahn Board of Directors recommends
you vote FOR the following Proposals:
4 Proposal 1. To approve the issuance of
shares of Rexahn common stock, $0.0001
par value per share, to stockholders of
Ocuphire pursuant to the terms
of the Agreement and Plan of Merger and
4 Proposal 2. To approve the plan to effect
a reverse stock split of Rexahn
common stock, at a ratio ranging from
1-for-3 to 1-for-5.
4 Proposal 3. To change the corporate name
from “Rexahn Pharmaceuticals, Inc.”
to “Ocuphire Pharma, Inc.”
4 Proposal 4. To approve the adoption of
the Ocuphire Pharma, Inc.
2020 Equity Incentive Plan.
4 Proposal 5. To approve the issuance of:
(1.) shares of Rexahn common stock
to be issued in the Pre-Merger Financing,
and (2.) the issuance of
additional shares of Rexahn common stock
that may be issued
following the closing of the Pre-Merger
4 Proposal 6. To approve an adjournment of
the Rexahn special meeting, if necessary,
to solicit additional proxies if there are
not sufficient votes in favor of
Proposal Nos. 1, 2, 3, 4 or 5.
As a Rexahn Pharmaceuticals, Inc.
Stockholder your vote matters
now more than ever.